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osting by EAbstract Leptospirosis, a zoonosis of global importance and it is underreported in India and more
than 50,000 severe cases are reported each year. Here we present the evaluation of 16S rRNA based
nested PCR assay for the rapid identiﬁcation of human leptospires using serum and urine samples.
The study includes 261 suspected cases for leptospirosis with different clinical manifestations. 16S
rRNA based nested PCR assay was compared and evaluated against the conventional serological
methods such as MAT and ELISA. The technique enabled ampliﬁcation of a 289 bp product with
notable percentage of positivity in all sample groups including 94.8 in pediatric cases, 93 in pregnant
women, 94.2 in renal failure, 87.8 in jaundice and 94.6 in common febrile cases. The sensitivity and
speciﬁcity was 94.4% and 100%, respectively. The technique proved to be prompt and effective for
the diagnosis of leptospiral infection at the acute phase of the disease. PCR based approach detects
leptospiral DNA from the clinical samples both at the acute and leptospiruria phase on comparison
with its counter parts where detection is made possible only after 7 days or 7–30 days post-infection.
In this regard PCR based diagnosis of leptospirosis should be made available for clinicians for the
early diagnosis and prompt treatment of the disease.
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lsevier1. Introduction
Leptospirosis is a reemerging zoonotic infectious disease
caused by pathogenic Leptospira species globally in both urban
and rural areas with inestimable morbidity and mortality (Vi-
netz, 2001). Its severe disease form, known as Weil’s syndrome
is an acute febrile illness associated with multiorgan system
complications including jaundice, renal failure, meningitis
and pulmonary hemorrhage, with a mortality rate exceeding
15% (Faine et al., 1999; Marotto et al., 1999).The clinical pre-
sentation of leptospirosis in humans is difﬁcult to distinguish
from dengue, malaria, inﬂuenza, and many other diseases
152 K. Natarajaseenivasan et al.characterized by fever, headache, and myalgia (Levett, 2001).
Early and accurate diagnosis of leptospirosis is important for
proper and prompt treatment, which is life saving for patients
with severe illness. Classic diagnosis of leptospirosis in humans
is made by demonstration of the organism using dark-ﬁeld
microscopy, isolation of the bacteria from tissue or body ﬂuids
by using speciﬁc media. The microscopic agglutination test
(MAT) used as a gold standard diagnostic technique for lepto-
spirosis is currently the primary diagnostic tool for current and
past infections. However, the MAT encounters several draw-
backs, which requires maintenance of a broad range of Lepto-
spira serovars for live antigen preparations and expertised
technical assistance. The other serological methods like
enzyme-linked immunosorbent assay (ELISA), dipstick ELI-
SA and latex agglutination test (LAT) have already been eval-
uated but all these techniques suffer from their own limitations
(Wagenaar et al., 1994). Southern blot analysis (Pacciarini et
al., 1992), Dot-blot, and in situ hybridization analyses (Millar
et al., 1987; Terpstra et al., 1987; Zuerner and Bolin, 1988) have
overcome some of the limitations of serologic techniques.
However, none of these methods can provide deﬁnitive diagno-
sis of leptospirosis in a timely manner to aid clinicians for dis-
ease management.
To overcome all these limitations polymerase chain reaction
(PCR) have been used, which is considered sensitive and speciﬁc
for the rapid detection of Leptospira in clinical samples. Evalu-
ation of PCR based studies for the identiﬁcation and diagnosis
of leptospirosis has been reported elsewhere (Natarajaseenivasan
et al., 2010; Djadid et al., 2009; Slack et al., 2006; Majed et al.,
2005; Galloway and Levett, 2008; Morey et al., 2006;
Reitstetter, 2006; Ahmed et al., 2006; Perolat et al., 1994;
Richtzenhain et al., 2002). But the diagnosis of leptospirosis
at the acute phase of the disease calls for an urgent need for
an alternative method of PCRwith high sensitivity and speciﬁc-
ity. With this view point, in this study we used a PCR assay to
help diagnosis of leptospirosis at the acute phase of the disease
and compared the results with those of the MAT and ELISA.
2. Materials and methods
2.1. Study area and collection of clinical samples
The province of Tiruchirappalli, with its tropical climate and
an area of 4403.83 km, lies on the bank of the river cauvery
in the south of India. Agriculture related activities, cattle
and poultry husbandry and ﬁsheries are the major occupa-
tions. The climatic, environmental and socioeconomic condi-
tions are suitable for the prevalence of human leptospirosis
in this particular study area. 75 urine and 186 blood samples
making a total of 261 clinical samples were collected during
monsoon period (September–November, 2009) from the pa-
tients with history and clinical manifestations suggestive of lep-
tospirosis admitted to Annal Mahatma Gandhi General
Hospital, Tiruchirappalli, Tamil Nadu.
For serum samples, 3 ml of blood was collected, allowed to
clot at room temperature, centrifuged and serum stored at
20 C until DNA isolation. In case of urine samples 10 ml
of urine was collected in a 15 ml container, to it added 10 ll
of formalin (ﬁnal concentration 0.1%) and stored the sample
at 4 C until use. It was then centrifuged at 1500g for 30 min
and the resulting supernatant was discarded and the pellets con-
taining leptospires were resuspended in 300 ll of phosphate-buffered saline (PBS) (pH 7.2) and stored at 20 C until use
(Boom et al., 1990). The sample groups were divided based
on the age and physiological complications viz pediatrics, renal
failure, cirrhosis, pregnant women and pyrexia of unknown ori-
gin (PUO). Informed written consent was obtained from all the
patients enrolled in the study. This study was approved by
Institutional ethics committee (IEC) of Bharathidasan Univer-
sity (Ref No. DM/2007/101/373/ Project No. 2).
2.2. Serology
To establish a titer rise, the MAT was applied according to the
standard method (Faine et al., 1999). A battery of 12 leptospiral
reference strains Australis (serovar Australis, strain Jez-Brati-
slava), Autumnalis (serovar Autumnalis, strain Akiyami A),
Ballum (serovar Ballum, strain Mus 127), Bataviae (serovar
Bataviae, strain Swart), Canicola (serovar Canicola, strain
Hond Utrecht IV), Icterohemorrhagiae (serovar Ictero
hemorrhagiae, strain RGA), Grippotyphosa (serovar Grippo-
typhosa, strainMoskva V), Hebdomadis (serovar Hebdomadis,
strainHebdomadis), Javanica (serovar Poi, strain Poi), Pomona
(serovar Pomona, strain Pomona), Sejroe (serovar Hardjo,
strain Hardjoprajitno) Pyrogenes (serovar Pyrogenes, strain
Salinem) was used as antigens. ELISA was performed as
described previously (Terpstra etal., 1985). The sonicated whole
cell lysate of serovar Icterohemorrhagiae strain RGA was used
as antigen and anti-human HRP and anti-human ALP (Sigma,
USA) as conjugate in IgG and IgM-ELISA respectively.
2.3. Extraction of DNA from clinical samples
DNA was extracted according to the method described earlier
(Boom et al., 1990) with minor modiﬁcations. Serum (100 ll)
or pretreated urine sample (300 ll) was mixed with nine vol-
umes of GuSCN-lysis buffer [10.15 M Guanidine thiocyanate
(GuSCN) (Amresco, USA), 22 ml of 0.2 M EDTA, 2.6 ml of
Triton X 100 (Amresco, USA) in 100 ml of 0.1 M Tris HCl
(pH 6.4)]. Subsequently, 40 ll of diatom suspension [0.5 ml
of 36% (v/v) HCl and 3.32 M diatoms (Sigma, USA) in
50 ml of H2O] was added and vortexed thoroughly. The mix-
ture was left at room temperature for 10 min. The diatoms
complexed with DNA were rapidly sedimented by centrifuga-
tion, washed twice with a GuSCN containing wash buffer
[10.15 M GuSCN in 100 ml of 0.1 M Tris–HCl (pH 6.4)], twice
with 70% (v/v) ethanol, and once with acetone and ﬁnally
dried at 56 C. DNA was eluted from the diatoms by incuba-
tion in distilled H2O for 10 min at 56 C and subsequently trea-
ted with proteinase K (250 lg/ml ﬁnal concentration) for
10 min. Finally proteinase K was inactivated by incubation
at 100 C for 15 min. The whole content was centrifuged at
16,000g for 2 min. The resulting aqueous phase served as a
source of DNA from clinical specimens.
2.4. Nested PCR ampliﬁcation
Nested PCR assay was performed with two pairs of speciﬁc
primers as described earlier (Me´rien et al., 1992). The primers
used for primary ampliﬁcation were 50-GGCGGCGCGTC
TTAAACATG-30 and 50-GTCCGCCTACGCACCCTTTA
CG-30. The ﬁrst round of ampliﬁcation was performed in 50 ll
reaction mix containing 10· Taq buffer, 3 mM MgCl2,
200 lMdNTPs, 0.5 U ofTaq polymerase (Fermentas), and pair
Table 1 Evaluation of different diagnostic methods and distribution of different cases.
S. No Disease type/case distribution No of samples Results
MAT (%) IgM (%) IgG (%) PCRa(%)
1 Pediatric cases 58 39 (67.2) 41 (70.6) 43 (74.1) 55 (94.8)
2 Pregnant women 43 25 (58.1) 28 (65.1) 31 (72) 40 (93)
3 Renal failure 52 41 (78.8) 44 (84.6) 46 (88.4) 49 (94.2)
4 Jaundice 33 18 (54.5) 19 (57.5) 23 (69.6) 29 (87.8)
5 Pyrexia of unknown origin (PUO) 75 48 (64) 53 (70.6) 57 (76) 71 (94.6)
a Positivity by 16S rRNA nested PCR.
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DNA. The temperature proﬁle for ampliﬁcation was as follows:
initial denaturation at 95 C for 5 min, denaturation at 95 C for
1 min, annealing at 60 C for 45 s and extension at 72 C for
1 min, for30cycles, followedbyaﬁnal extensionat72 Cfor7 min.
The second round of ampliﬁcation was carried out using 1 ll
of the ﬁrst PCR product as template using the primers 50-
CAAGTCAAGCGGAGTAGCAA-30 and 50-TAACCTGCT
GCCTCCCGTA-30. The same conditions and program of
ampliﬁcation were followed as for the ﬁrst round except the
annealing was set at 62 C for 45 s. Each PCR reaction was
performed thrice by at least three individuals for consistency
and a negative for each round of PCR was maintained. The
ampliﬁed products were separated on 1.2% agarose gel stained
with ETBr and visualized in a gel documentation system
(Bio-Rad, USA).
2.5. Speciﬁcity of the PCR assay
The speciﬁcity of the primer used in the PCR was tested with
the DNA extracted from microorganisms generally involved inFigure 1 Nested PCR based detection of human leptospirosis. M- 1 k
from serum samples, 6 to 10-Ampliﬁcation from urine samples, 11-Asvarious clinical manifestations namely Escherichia coli,
Salmonella typhimurium and Staphylococcus aureus.
3. Results
Different diagnostic tests were employed for the detection of
leptospirosis in patients with different clinical manifestation
viz., pediatric, pregnant women, renal failure, cirrhosis, and
PUO. The results obtained envisaged that there was a signiﬁ-
cant difference (P< 0.05) between different tests for the diag-
nosis of leptospirosis but no signiﬁcant difference was
observed (P> 0.05) in the incidence of leptospirosis between
cases with different clinical manifestations. The results from
261 suspected cases tested by PCR, MAT, ELISA are shown
in Table 1. Among the 261 cases, 171 (65.5%) were positive
by MAT, 185 (70.8%) by IgM-ELISA, 200 (76.6%) by IgG-
ELISA and 244 (93.8%) by PCR. In all 244 samples, a
289 bp product was detected by agarose gel electrophoresis
(Fig. 1). The sensitivity, speciﬁcity, negative predictive value,
positive predictive value for IgM ELISA, IgG ELISA and
PCR Vs the gold standard test MAT are shown in Table 2.b Molecular Marker, 1-Positive control DNA, 2 to 5-Ampliﬁcation
say control.
Table 2 Sensitivity, speciﬁcity, PPV and NPV of different
diagnostic methods on comparison with MAT.
Factor MAT vs
IgM ELISA
MAT vs
IgG ELISA
MAT vs
PCR
Sensitivity (%) 92.7 94.7 97
Speciﬁcity (%) 89 93 96
Positive predictive value (%) 76 83 89
Negative predictive value (%) 91.9 95.3 87.3
154 K. Natarajaseenivasan et al.Point estimates of sensitivity and speciﬁcity ranged from 92.7–
97% and 89–96%, respectively. Test speciﬁcity was notably
higher for MAT vs PCR with point estimate as 96%. The
PCR primers used in the present study was found to be highly
sensitive only to leptopsiral 16S rRNA gene, which is genus
conserved among the prokaryotes (Fig. 2).
4. Discussion
Leptospirosis is one of the important reemerging diseases in
developing countries, not only for the increase in its occurrence
during the past decade but also due to increased frequency of
mortality especially in patients with delayed diagnosis and im-
proper treatment. Even though some standard serologicalmeth-
ods like MAT and ELISA are available, they have their own
limitations. This study demonstrates leptospiral infection in a
large proportion of suspected cases by PCRwhich was relatively
higher than that from the conventional serological methods.
This condition can be well explained. During the acute phase
of the infection, the leptospires will be circulating in blood and
in leptospiruria phase the immune system develops antibody
and thus leads to clearing of leptospires fromblood and excreted
in the urine. Thus during the acute phase of infection, serologicalFigure 2 Validation of the primers used for 16S rRNA nested PC
Australis, (2) L. interrogans Autumnalis, (3) L. interrogans Canicola,
AlexanderiManhao, (7) L. borgpetersenii Javanica, (8) L. borgpeterseni
(11) L. kirschneri Grippotyphosa, (12) L. noguchii Lousiana, (13) Esch
Negative control.tests may be negative. To circumvent the problems associated
with detecting and interpreting immune responses, the use of
PCR to detect DNA of leptospires seems promising. Further-
more as a result of the present study we claim that PCR tech-
niques hold good not only for the diagnosis of infection at the
acute phase but also seems hopeful to detect leptospiruria phase
too. But the sensitivity and speciﬁcity of the technique greatly
depends upon the clinical specimens included in the study. The
failure of PCR in certain serologically conﬁrmed cases can be
attributed to the absence of the organisms in blood or due to
the degradation of DNA during prolonged sample storage or
the microbial counts that were reasonably low the detection
limit of the assay which may be about ﬁve cells. The MAT is a
speciﬁc method because of its antigenic heterogeneity of Lepto-
spira serovars and it requires a large number of serovars as anti-
gens. In addition it would not be useful at the early stages of the
disease when the antibody toLeptospira is not present or if pres-
ent at a very low level. But detection of leptospirosis at the acute
phase can save life of patients suffering from the disease. In this
regard detection of leptospires by using polymerase chain reac-
tion should be a sensible method for the early diagnosis of
leptospirosis.
5. Conclusion
Early diagnosis of leptospirosis is critical because of the risk of
severe complications of the disease including pancreatitis, lung
and intracranial hemorrhages, which requires intense care ther-
apy. The results of the present study envisaged that PCR has
advantages overMAT and ELISA for the early and late diagno-
sis of leptospiral infection and its sensitivity depends upon the
clinical specimen tested. The technique holds good for screening
large number of samples with different clinical manifestations.R ampliﬁcation. M-1 kb Molecular Marker, (1) L. interrogans
(4) L. interrogans Hebdomadis. (5) L. interrogans Pomona, (6) L.
i Ballum, (9) L. borgpetersenii sejroe, (10) L. kirschneri Cyanopteri,
erichia coli, (14) Salmonella typhi, (15) Staphylococcus aureus, (16)
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